We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Foley Catheter Versus Cervidil for Induction of Labor at Term

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01402050
Recruitment Status : Completed
First Posted : July 26, 2011
Results First Posted : February 6, 2020
Last Update Posted : March 2, 2020
Sponsor:
Information provided by (Responsible Party):
Pediatrix

Study Type Interventional
Study Design Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: None (Open Label);   Primary Purpose: Treatment
Condition Labor Induction
Interventions Drug: CERVIDIL (Dinoprostone)
Device: FOLEY BALLOON
Enrollment 376
Recruitment Details  
Pre-assignment Details  
Arm/Group Title FOLEY BALLOON CERVIDIL
Hide Arm/Group Description

Comparing Foley balloon to Cervidil for decreased time from the start of the induction process to delivery is the aim of this RCT.

Subjects randomized into the Foley Balloon Arm received a Foley Balloon past the cervical os filled with 30 cc of sterile water, and catheter taped to inside of maternal thigh. Catheter was removed for any of the 5 reasons: expulsion, nonreasurring fetal heart rate tracing mandating placement of internal monitors, tachysystole, spontaneous membrane rupture, or 12 hours elapsed since placement.

Key words: FOLEY BALLOON: INDUCTION OF LABOR

CERVIDIL (Dinoprostone) Arm: Subjects randomized to this arm received dinoprostone controlled release vaginal insert (standard dosing Cervidil, 0.3mg/hour of dinoprostone over 12 hours). The vaginal insert was placed in the posterior fornix and was removed for any of the 5 reasons stated for the Foley catheter Arm description. Fetal heart rate and uterine contractions were continuously monitored per standard. Time of placement was noted as the time of Labor Induction initiation and time of delivery was noted as the end time of Labor Induction.

Key word: INDUCTION OF LABOR

Period Title: Overall Study
Started 185 191
Completed 185 191
Not Completed 0 0
Arm/Group Title FOLEY BALLOON CERVIDIL Total
Hide Arm/Group Description

Comparing foley balloon to cervidil for decreased time from the start of the induction process to delivery

FOLEY BALLOON: INDUCTION OF LABOR

CERVIDIL (Dinoprostone): INDUCTION OF LABOR Total of all reporting groups
Overall Number of Baseline Participants 185 191 376
Hide Baseline Analysis Population Description
[Not Specified]
Age, Continuous  
Mean (Standard Deviation)
Unit of measure:  Years
Number Analyzed 185 participants 191 participants 376 participants
28.0  (6.4) 26.9  (5.9) 27.5  (6.2)
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 185 participants 191 participants 376 participants
Female
185
 100.0%
191
 100.0%
376
 100.0%
Male
0
   0.0%
0
   0.0%
0
   0.0%
Race/Ethnicity, Customized  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 185 participants 191 participants 376 participants
White
87
  47.0%
81
  42.4%
168
  44.7%
Black
34
  18.4%
33
  17.3%
67
  17.8%
Hispanic
44
  23.8%
60
  31.4%
104
  27.7%
Other
20
  10.8%
17
   8.9%
37
   9.8%
Region of Enrollment  
Measure Type: Number
Unit of measure:  Participants
United States Number Analyzed 185 participants 191 participants 376 participants
185 191 376
1.Primary Outcome
Title Time Of Start Of Induction Of Labor To Delivery
Hide Description

The primary outcome variable was time (measured in hours) from first attempt at study agent placement to delivery. Time of placement of Labor Induction agent was noted as the time of Labor Induction initiation and time of delivery was noted as the end time of Labor Induction.

There were no specific time points at which the outcomes were measured due to the uncertainty of the labor process. Total time duration of Labor induction was noted in hours.

Key word: INDUCTION OF LABOR

Time Frame Hours
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title FOLEY BALLOON CERVIDIL
Hide Arm/Group Description:

Comparing foley balloon to cervidil for decreased time from the start of the induction process to delivery

FOLEY BALLOON: INDUCTION OF LABOR

CERVIDIL (Dinoprostone): INDUCTION OF LABOR
Overall Number of Participants Analyzed 185 191
Median (Inter-Quartile Range)
Unit of Measure: hours
21.6
(15.7 to 35.1)
26.6
(19.0 to 37.8)
Time Frame [Not Specified]
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title FOLEY BALLOON CERVIDIL
Hide Arm/Group Description

Comparing foley balloon to cervidil for decreased time from the start of the induction process to delivery

FOLEY BALLOON: INDUCTION OF LABOR

CERVIDIL (Dinoprostone): INDUCTION OF LABOR
All-Cause Mortality
FOLEY BALLOON CERVIDIL
Affected / at Risk (%) Affected / at Risk (%)
Total   --/--      --/--    
Hide Serious Adverse Events
FOLEY BALLOON CERVIDIL
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total   0/185 (0.00%)      0/191 (0.00%)    
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
FOLEY BALLOON CERVIDIL
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total   0/185 (0.00%)      2/191 (1.05%)    
Gastrointestinal disorders     
Neonatal event * [1]  0/185 (0.00%)  0 2/191 (1.05%)  2
*
Indicates events were collected by non-systematic assessment
[1]
Neonatal death due to pre-existing prenatally diagnosed diaphragmatic hernia
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Ana Braescu
Organization: Phoenix Perinatal Associates - Mednax
Phone: 602-614-0488
EMail: ana_braescu@mednax.com
Layout table for additonal information
Responsible Party: Pediatrix
ClinicalTrials.gov Identifier: NCT01402050    
Other Study ID Numbers: 01-10-0012
First Submitted: April 8, 2011
First Posted: July 26, 2011
Results First Submitted: January 24, 2020
Results First Posted: February 6, 2020
Last Update Posted: March 2, 2020